جستجوی استاد راهنمای دانشگاهی

برای مسیر پژوهشی‌تان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آن‌ها ارتباط بگیرید.

نمایش ۱۶-۳۰ از ۶۱ استاد راهنما

اطلاعات پروفایل‌ها از صفحات عمومی دانشگاه‌ها گرفته شده و ممکن است به‌روز نباشد.

Chandrika Behuraمشاهده پروفایل

دانشیار

Penn State College of MedicineUnited States

Dr. Chandrika Behura is an Associate Professor in the Department of Pediatrics, Division of Hematology and Oncology at Penn State College of Medicine. She is a board-certified hematologist/oncologist with a strong commitment to research in childhood cancer, particularly leukemia and neuroblastoma. Her work is supported by several extramural grants and she has established herself as a national leader in pediatric hematology/oncology research. Dr. Behura's research focuses on the role of Ikaros tumor suppressor and pro-oncogenic casein Kinase II (CK2) in leukemogenesis and drug resistance. Her most notable work, published in Blood in 2015, established a novel approach of using specific CK2 inhibitors for treatment of high-risk B cell lineage leukemia using PDX models. She has presented her work at various national and international scientific forums and gained national recognition as an outstanding young investigator. Analysis of Dr. Behura's publications reveals a consistent focus on molecular mechanisms of childhood leukemia, particularly the role of CK2 signaling pathways. Her research spans basic science investigations of gene regulation in hematopoietic cells to clinical applications of novel therapeutics. Recent work has expanded into cancer epidemiology and educational innovations for physician-scientist training. Distinguished Educator Award (2024) Outstanding Early-Stage Investigator Award (2018) Scholarship in Education Award (2022) Dr. Behura's research is currently supported by several extramural grants. She has also authored numerous chapters and review articles related to leukemia, CK2 and Ikaros. Her work contributes to UN Sustainable Development Goals related to good health and well-being. She is actively involved in the Penn State Cancer Institute and Penn State Neuroscience Institute, focusing on next-generation therapies for childhood cancers.

پروفایل رسمی دانشگاه

J. Scott Haleمشاهده پروفایل

دانشیار

University of UtahUnited States

J. Scott Hale is an Associate Professor in the Department of Microbiology and Immunology at the University of Utah, affiliated with the Molecular Biology Program. His research explores T cell differentiation, immunological memory, and anti-viral immunity using murine models. He earned a B.A. from the University of Utah and a Ph.D. from the University of Washington. Research Focus: Dr. Hale investigates how CD4+ T cells differentiate into specialized subsets (Th1 and Tfh) during viral infections, examining epigenetic regulators like DNA methylation and transcription factors (e.g., Tbet) that control memory T cell development. His lab aims to translate these insights into improved vaccine strategies for long-lasting immunity. Publication Trends: Recent work (2013-2023) emphasizes T follicular helper cell biology, mechanisms of immunological memory, and vaccine efficacy assessment, with consistent focus on epigenetic controls of T cell fate in infection contexts.

پروفایل رسمی دانشگاه

Erastus C. Dudleyمشاهده پروفایل

استاد

Huntingdon CollegeUnited States

Erastus C. Dudley is a Professor of Biology at Huntingdon College, where he is actively involved in teaching, advising, and mentoring. He serves as the Cell Biology Program Coordinator, reflecting his leadership in academic programming within the Department of Biology in the College of Arts and Sciences. Dr. Dudley earned his B.S. from Yale College, followed by an M.S., M.Phil., and Ph.D. from Yale University. He was a National Science Foundation Graduate Fellow (1988–92) and later a Jane Coffin Childs Memorial Fund Fellow at the National Institutes of Health, underscoring his strong research foundation in molecular and cellular immunology. His research focuses on T-cell development, receptor signaling, and cell fate decisions, particularly in αβ and γδ T-cell lineages. He has made significant contributions to understanding apoptosis, TCR gene rearrangement, and epithelial immune surveillance. His earlier work in paleobiology explored predation patterns in mollusks, demonstrating interdisciplinary depth. The publication record shows a strong concentration in immunology from 1991 to 2001, with key articles in Cell , Immunity , and EMBO Journal . The research integrates molecular mechanisms with developmental biology, emphasizing signaling pathways like NF-kB and Fas-mediated apoptosis, and exploring the role of T-cell receptors in lineage commitment. Dr. Dudley has received multiple honors, including: Julia Lightfoot Sellers Award (2017, 2002) Exemplary Teacher Award (2007) Dr. and Mrs. John N. Todd Award for Excellence in Teaching (2001) Winn and Gordon Chappell Academic Enrichment Award (2011) Dr. and Mrs. John N. Todd III Award for Excellence in Administration (2010) Jane Coffin Childs Fellow (1997–98) National Science Foundation Graduate Fellow (1988–92) He is deeply committed to holistic education, mentoring students both in and out of the classroom. Though no formal list of advisees is provided, his quote emphasizes advising and mentorship as core to his role. He has not been associated with major external grants in the text, but his fellowship history indicates strong early-career funding support. His work bridges fundamental immunology with evolutionary perspectives, suggesting a unique integrative approach. Dr. Dudley is associated with the Biology Department and leads the Cell Biology Program. While no formal lab name is mentioned, his research on thymocyte development and T-cell signaling implies a cell and molecular biology laboratory environment focused on immunological mechanisms.

پروفایل رسمی دانشگاه

Yongsheng Shiمشاهده پروفایل

استاد

University of California, IrvineUnited States

Yongsheng Shi is a Professor & Chancellor's Fellow in the Department of Microbiology & Molecular Genetics at the University of California, Irvine (UCI). His research focuses on the molecular mechanisms of RNA processing, particularly mRNA 3' end formation, polyadenylation, and their roles in gene expression regulation. He investigates how these processes influence cellular differentiation, viral pathogenesis, and cancer biology. Key research interests include transcriptome surveillance, RNA-protein interactions, and the interplay between RNA processing and epigenetic regulation. His work employs cutting-edge techniques like PAS-seq and massively parallel reporter assays, combined with machine learning approaches, to decode complex RNA regulatory networks. Shi's publications highlight contributions to understanding herpes simplex virus effects on host mRNA processing, the role of polyadenylation in stem cell self-renewal, and the functional implications of RNA structure in gene regulation. His findings bridge basic molecular mechanisms with translational applications in cancer therapy and viral infections. He holds the prestigious Chancellor's Fellow title at UCI, reflecting recognition of his scholarly contributions. His research has implications for understanding fundamental biological processes and developing therapeutic strategies targeting RNA machinery.

پروفایل رسمی دانشگاه

Michael G. Kharasمشاهده پروفایل

استاد

Cornell UniversityUnited States

Michael G. Kharas is a Professor at Weill Cornell Medicine's Pharmacology Graduate Program and an Investigator at Memorial Sloan-Kettering Cancer Center's Molecular Pharmacology Program. His research focuses on RNA regulators in hematopoietic stem cells and leukemia pathogenesis, particularly Musashi-2 and m6A methylation mechanisms. Dr. Kharas investigates how post-transcriptional RNA regulation affects symmetric/asymmetric cell division balance in HSCs and leukemic stem cells. His lab develops small molecules targeting RNA-binding proteins and studies metabolic adaptations in leukemia, including fructose utilization and serine synthesis pathways. Current projects explore RNA methylation, chromatin regulation, and screening approaches for self-renewal modulation. His publications reveal trends in RNA biology, epigenetics, and leukemic stem cell targeting. Key subfields include m6A-dependent differentiation control, Musashi-2 networks, metabolic dependencies, chromatin maintenance, and therapeutic strategies against RNA regulators. Leukemia and Lymphoma Society Career Development Award Alex Lemonade Stand Foundation ‘A’ Award American Society of Hematology Junior Faculty Scholar Award Kimmel and V-Scholar Awards Louis V. Gerstner Young Investigator Award As lab head, he mentors researchers and collaborates across institutions. His work spans basic HSC biology, translational leukemia models, and drug discovery platforms targeting RNA-protein interactions.

پروفایل رسمی دانشگاه

Tiziana Corselloمشاهده پروفایل

استادیار

The University of Texas Medical Branch at GalvestonUnited States

Tiziana Corsello is an Assistant Professor at the University of Texas Medical Branch at Galveston (UTMB) in the Department of Pediatrics, Division of Clinic and Experimental Immunology and Infectious Disease. Her research focuses on respiratory viral infections in children, emphasizing viral, environmental, and host-specific mechanisms contributing to disease pathogenesis. Education: PhD in Neuroscience, University of Texas Medical Branch at Galveston. Postdoctoral Fellow, NIEHS T32 Environmental Toxicology Training Program at UTMB. Jeane B. Kempner Scholar at UTMB. Her work explores translational strategies for environmental exposure detection (biomarkers) and antiviral therapies. Recent studies highlight the role of extracellular vesicles (EVs) in RSV pathogenesis and the hepatogenic potential of mesenchymal stromal cells from preterm umbilical cords. She employs proteomic profiling and piRNA analysis to uncover molecular mechanisms. Scientific Awards: UTMB Institute for Translational Sciences Provost’s Scholar Award (2022). Dr. Corsello leads two active projects: (1) Protein Cargo and Antiviral Properties of Epithelial-derived EVs in RSV Infection (Parker B. Francis Fellowship Program, 2024–2027), and (2) Role of Airway Derived EVs in Respiratory Viral Infections (American Lung Association, 2023–2025). Her research has garnered media attention, including a 2023 UTMB News feature on extracellular vesicle funding.

پروفایل رسمی دانشگاه

Heather Melicharمشاهده پروفایل

دانشیار

University of MontrealCanada

Dr. Heather Melichar is an Associate Professor in the Department of Medicine at the University of Montreal, where she leads a research group at the Maisonneuve-Rosemont Hospital Research Center. With a PhD from the University of Massachusetts Medical School and postdoctoral training at UC Berkeley, her work focuses on the cellular and molecular mechanisms regulating T cell development and function, particularly through thymic microenvironment interactions. Doctoral: University of Massachusetts Medical School (Dr. Joonsoo Kang lab) Postdoctoral: University of California, Berkeley (Dr. Ellen Robey lab) Her research employs advanced techniques like multiparameter flow cytometry, two-photon microscopy, and genetically modified mouse models to investigate: TCR selection thresholds during thymocyte development Age-related differences in thymic selection Role of tissue-restricted antigens in mTEC Tumor-immune cell interactions via novel protein-protein signaling Key article trends reveal sustained focus on developmental immunology, with recent expansions into neuroimmunology, metabolic disorders, and tumor immunology. Her 2023-2025 work includes translational studies on navitoclax therapy and epigenetic impacts of early-life infections. Scientific awards include FRSQ and CIHR fellowships. Current grants support investigations into vitamin D signaling in thymic aging and tumor-immune crosstalk. She supervises graduate students and postdoctoral fellows in laboratory projects, while co-supervising with interdisciplinary collaborators in genetics and oncology.

پروفایل رسمی دانشگاه

Rochelle A. Diamondمشاهده پروفایل

پژوهشگر

California Institute of Technology (Caltech)United States

Rochelle A. Diamond is a Member of the Professional Staff at the California Institute of Technology (Caltech) and currently serves as Facility Director Emerita of the Flow Cytometry/Cell Sorting Facility. She has specialized in cell separation and analysis techniques—including flow cytometry, magnetic bead separation, and centrifugation—since 1984, providing consultation, training, and instrument support to over 30 Caltech laboratories annually. Her research focuses on cellular and developmental immunology, particularly early murine T-cell differentiation. She has co-authored over 25 publications and contributed to the professional text In Living Color: Protocols in Flow Cytometry and Cell Sorting (Springer, 2000). Her work has involved collaborations with institutions like the National Institutes of Health, Wiley and Sons, and RG Landes. Rochelle's publications span immunology, molecular biology, and analytical chemistry, with a strong emphasis on T-cell development, transcriptional regulation, and flow cytometry applications. She has also contributed to community-building initiatives, including symposia and workshops on LGBTQA networking and diversity in science. Scientific awards include: Lesbians and Bisexual Women Active in Community Empowerment (L.A.C.E.) Award Walt Westman Volunteer of the Year Award Fellow of the American Association for the Advancement of Science (AAAS) Diamond has reviewed grant applications for the National Institutes of Health and served on editorial boards for scientific publishers. She also manages the Rothenberg Research Group's day-to-day operations and lab safety protocols.

پروفایل رسمی دانشگاه

Venetia Bigleyمشاهده پروفایل

پژوهشگر ارشد

Newcastle UniversityUnited Kingdom

Dr Venetia Bigley is a Research Fellow at Newcastle University specializing in immunology and hematopoietic stem cell transplantation for primary immunodeficiencies. Her work focuses on dendritic cell and monocyte deficiencies, particularly GATA2-related disorders and CTLA-4 insufficiency, with extensive collaboration through the European Society for Blood and Marrow Transplantation Inborn Errors Working Party. Her research encompasses: Genetic basis of primary immunodeficiencies including DCML deficiency and histiocytic disorders Mechanisms of dendritic cell development and function in health and disease Optimization of stem cell transplantation protocols for inborn errors of immunity Molecular characterization of novel immune dysregulation syndromes International registry studies for rare immunological conditions Analysis of her 2021-2025 publications reveals dominant themes in translational immunology, with emphasis on genetic discovery (GATA2, CARMIL2), therapeutic innovation in stem cell transplantation, and international collaboration for rare diseases. Her work bridges molecular immunology with clinical applications, particularly in hematopoietic disorders requiring transplant intervention. Scientific Awards: None documented in provided materials. Advising and Grants: While specific student names and grant details aren't listed, her senior authorship on 50+ publications indicates significant mentorship of junior researchers and likely involvement in major institutional and international funding initiatives supporting immunology and transplantation research. Labs and Teams: Dr Bigley operates within Newcastle University's Immunology Research Group led by Professor Matthew Collin, maintaining active roles in EBMT Working Parties and European collaborative networks focused on primary immunodeficiencies and histiocytic disorders.

پروفایل رسمی دانشگاه

Ian Dimmickمشاهده پروفایل

پژوهشگر

Newcastle UniversityUnited Kingdom

Ian Dimmick is a researcher at Newcastle University with a focus on immunology, hematology, and biomarker discovery for critical illnesses. His work spans immunophenotyping, stem cell differentiation, and cell surface marker analysis in clinical contexts. Research Interests : Immune dysfunction in critical care Biomarker identification for sepsis T-cell and dendritic cell behavior in disease Hematopoietic stem cell differentiation Flow cytometry methodology Publication Trends : Recent studies highlight immunophenotyping in sepsis and myocardial infarction (2015-2018), with earlier work on stem cell biology and ocular surface markers (2005-2011). Collaborations include clinical immunology and hematopoietic niche modeling.

پروفایل رسمی دانشگاه

Anthony E. Oroمشاهده پروفایل

استاد

Stanford UniversityUnited States

Anthony E. Oro, M.D., Ph.D., is the Eugene and Gloria Bauer Professor of Dermatology at Stanford University School of Medicine. He serves as Associate Director of the Center for Definitive and Curative Medicine and co-director of the Child Health Research Institute. Dr. Oro is a co-founder of the Program in Epithelial Biology and maintains active membership in multiple prestigious research institutes including the Institute for Stem Cell Biology and Regenerative Medicine, Children's Health Research Institute, Bio-X, and the Program in Cancer Biology. Dr. Oro's research laboratory focuses on skin stem cells to understand mechanisms of tissue regeneration and carcinogenesis, with particular emphasis on Sonic hedgehog (Shh) signaling in hair follicles and basal cell carcinoma (BCC) pathogenesis. His team provided clinical evidence for the first hedgehog pathway inhibitor and continues to develop novel targets for next-generation inhibitors. His work spans cancer genomics, tumor evolution, stem cell biology, hair/skin development and regeneration, and molecular therapeutics. His clinical practice focuses on cutaneous oncology, non-melanoma skin cancer, hair disorders, and stem cell-based therapies for genetic skin diseases like Epidermolysis Bullosa. Dr. Oro has led multiple clinical trials investigating novel therapies for advanced basal cell carcinoma and other dermatological conditions. Eugene and Gloria Bauer Professor of Dermatology Associate Director, Center for Definitive and Curative Medicine Co-Director, Child Health Research Institute Member, Institute for Stem Cell Biology and Regenerative Medicine Member, Bio-X Member, Stanford Cancer Institute Member, Wu Tsai Neurosciences Institute Dr. Oro's extensive publication record demonstrates leadership in understanding tumor heterogeneity, resistance mechanisms in basal cell carcinoma, and developing stem cell-based therapies for genetic skin disorders. His research has identified critical pathways in tumor evolution and therapeutic resistance, particularly regarding non-canonical Hedgehog signaling mechanisms. Sonic hedgehog signaling in hair follicle development Basal cell carcinoma pathogenesis and resistance mechanisms Stem cell biology and skin regeneration Epidermal differentiation from pluripotent stem cells Therapeutic reprogramming for genetic skin diseases Tumor microenvironment interactions Dr. Oro has trained numerous graduate students, postdoctoral fellows, and medical scholars. His laboratory has made significant contributions to understanding transcription factor networks in epithelial development and identifying novel therapeutic targets for cancer treatment.

پروفایل رسمی دانشگاه

Rachel Gersteinمشاهده پروفایل

دانشیار

University of Massachusetts Chan Medical SchoolUnited States

Rachel Gerstein is an Associate Professor at UMass Chan Medical School (T.H. Chan School of Medicine) within the Department of Microbiology. She also holds positions in the NeuroNexus Institute, Cancer Biology, Immunology and Microbiology Program, Interdisciplinary Graduate Program, and Translational Science at Morningside Graduate School of Biomedical Sciences. Her academic background includes a BA in Biological Sciences from Smith College and a PhD in Biology from Brandeis University (1991). Education: BA (Smith College), PhD (Brandeis University) Key Research Areas: Developmental regulation of V(D)J recombination, B cell development, hematopoietic stem cell aging, immunoglobulin gene assembly, and tumor suppression mechanisms Gerstein’s lab investigates the molecular control of antibody gene rearrangement during B cell development using novel retroviral assays and GFP-based reporter systems. Her work spans immunology, molecular biology, and cancer biology, with significant contributions to understanding B lymphocyte lineage commitment, Notch signaling in leukemia, and age-related immune decline. Publications highlight collaborations in Animals and Humans models, focusing on Cell Biology and Neoplasms disciplines. Recent publications (2013–2023) demonstrate trends in Allergy and Immunology , Cell Biology , and Neoplasms , with subfields including V(D)J Recombination , Lymphoid Progenitors , Ubiquitin Ligase Activity , and Tumor Microenvironment . Her lab URL is https://www.umassmed.edu .

پروفایل رسمی دانشگاه

Michael G. Constantinidesمشاهده پروفایل

استادیار

Irell and Manella Graduate School of Biological SciencesUnited States

Michael G. Constantinides, PhD, is an Assistant Professor in the Department of Immunology and Microbiology at Scripps Research. His research focuses on the interplay between host microbiota and innate-like T cells, particularly MAIT cells, exploring how these cells are shaped by microbial communities and their roles in immunity, tissue repair, and disease. He leads the Constantinides Lab, which develops therapies targeting infectious diseases, autoimmunity, and cancer. Education: PhD in Immunology from the University of Chicago (2014), BA in Chemistry from Princeton University (2007). Research Interests: Microbiota-host dialog, immune cell development, MAIT cell biology, tissue homeostasis, and translational therapies. His lab uses interdisciplinary approaches to uncover mechanisms linking microbial ecology to immune function. Awards: AAI Pfizer-Showell Award (2024) NIGMS Maximizing Investigators’ Research Award (2023) Donald E. & Delia B. Baxter Foundation Faculty Scholar (2021) NIAID Career Transition Award (2021) Advancing Science: Recent lab milestones include identifying antibiotic impacts on MAIT cell immunity and discovering microbiota-driven imprinting of innate lymphocytes. Current projects aim to modulate microbiota-T cell interactions for therapeutic innovation. Lab Members: The lab includes researchers like Dominic Haas, Jonathan Melamed, and Gabrielle LeBlanc, supported by grants such as the NIH K22 and Baxter Foundation funding.

پروفایل رسمی دانشگاه

Eli Zunderمشاهده پروفایل

دانشیار

University of VirginiaUnited States

Eli Zunder, Ph.D., is an Associate Professor in the Department of Biomedical Engineering at the University of Virginia. His research focuses on analyzing stem cell fate using single-cell mass cytometry and high-dimensional modeling of cell lineage trajectories. He holds a B.A. from Dartmouth College (2002) and a Ph.D. in Biophysics from UCSF (2008), followed by postdoctoral training in Garry Nolan’s lab at Stanford University. His work has developed novel methods for cell barcoding in mass cytometry, mapping immune system organization, and identifying therapeutic targets in cancer and stem cell reprogramming. Research Interests: Biotechnology and Biomolecular Engineering, Computational Systems Biology, stem cell differentiation, immune system dynamics, and high-dimensional data analysis. His lab explores mechanisms controlling stem cell behavior in development and disease, with applications in regenerative medicine and drug discovery. Grants & Projects: Current research includes in vitro differentiation studies to define principles of pluripotency and lineage commitment. His lab develops experimental and computational tools for tracking cell populations at single-cell resolution, such as the FLOW-MAP trajectory mapping algorithm and ensemble clustering methods like ESCHR. Projects focus on neurodevelopment, immune system plasticity, and disease models like ALS and idiopathic pulmonary fibrosis. Labs & Teams: The Zunder Lab at the University of Virginia collaborates across disciplines to integrate cutting-edge cytometry techniques with systems biology approaches. Key collaborations include work on immune signaling dynamics and metabolic pathways in neurodegenerative diseases.

پروفایل رسمی دانشگاه

Ping Wangمشاهده پروفایل

استاد

Queen Mary University of LondonUnited Kingdom

Professor Ping Wang is a leading academic at the Blizard Institute , part of Queen Mary University of London , within the Faculty of Medicine and Dentistry . His work bridges immunology, molecular biology, and translational medicine. M.D., Suzhou Medical College, China (1983) M.S., Shanghai Cancer Institute, China (1986) Ph.D., Karolinska Institute (1992) Research Interests : Professor Wang's work focuses on the regulation of antigen processing and presentation via mechanisms like tapasin's role in MHC I peptide assembly. He pioneers nano-vaccine development for chronic infections (e.g., HBV) by engineering ER membrane particles to deliver antigens and cytokines directly to T cells. His team also investigates intrinsic regulation of B and T cells in autoimmunity and pathogen response, and Egr genes in lymphocyte function , including their control of immune tolerance and autoimmune disease prevention via Bcl6 and Batf regulation. Article Trends : His publications span immunology, cancer, virology, and biomedical engineering, with a focus on Egr transcription factors, nano-vaccine systems, antigen presentation mechanisms, and T/B cell interactions in autoimmunity and chronic disease. Recent work includes Tfh cell biology, oncolytic virus therapy optimization, and energy-efficient medical devices. Teaching : He instructs bioscience and medical students in membrane biology, tumor immunology, adaptive immunity, and transgenic models, while mentoring PhD candidates in immunological research. Funding : His work is supported by Arthritis Research UK and the Medical Research Council (MRC) , enabling clinical trials for HBV therapeutic vaccines and autoimmune disease studies.

پروفایل رسمی دانشگاه